Varenicline Treatment of Alcohol Dependence in Smokers

PHASE2CompletedINTERVENTIONAL
Enrollment

131

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2016

Conditions
AlcoholismAlcohol AbuseSmokingAlcohol Drinking
Interventions
DRUG

Varenicline

0.5 mg once per day for Days 1 to 3, 0.5 mg twice per day for Days 4 to 7, then two 0.5 mg tablets (1 mg) twice per day

Trial Locations (2)

10016

Parallax Center, New York

06511

Connecticut Mental Health Center - Substance Abuse Treatment Unit, New Haven

All Listed Sponsors
collaborator

Columbia University

OTHER

collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

Yale University

OTHER

NCT01553136 - Varenicline Treatment of Alcohol Dependence in Smokers | Biotech Hunter | Biotech Hunter